The systemic approach: Meibum pathophysiology, metabolic axis, stress, and microbiome.
In a systemic view, chronic blepharitis and Meibomian Gland Dysfunction (MGD) are rarely just "local infections". They often represent the ocular expression of chronic mucosal inflammation. When the tear film alters and recurrent chalazia appear, conventional ophthalmological therapy remains the central treatment. However, it may prove useful to explore potential underlying cofactors—such as metabolic profile, intestinal permeability, and neuro-immune reactivity—together with your attending physician.
Identifying basic mechanisms to clinically support relapse prevention.
The molecular mechanisms behind glandular blockage and redness.
These systemic and nutritional strategies aim to support lipid physiology, always strictly alongside essential ophthalmological medical therapies.
Modulating glycemic load and balanced Omega-3 (EPA/DHA) integration to counteract the arachidonic acid inflammatory cascade and attempt to restore a physiological meibum melting point.
Sleep hygiene and reducing systemic stress factors are crucial to deactivate trigeminal nerve hyper-reactivity, lowering the chronic sensation of burning and foreign body.
Warm-moist compresses (at 40°C) remain fundamental to melt stagnant waxy lipids, paired with targeted ciliary cleansing (e.g., Tea Tree Oil for confirmed Demodex proliferation).
Probiotic or prebiotic interventions aim to seal tight junctions, reducing the systemic passage of endotoxins that fuel distant ocular inflammation.